vs
Heritage Distilling Holding Company, Inc.（IPST）与Protalix BioTherapeutics, Inc.（PLX）财务数据对比。点击上方公司名可切换其他公司
Protalix BioTherapeutics, Inc.的季度营收约是Heritage Distilling Holding Company, Inc.的1.9倍（$9.1M vs $4.7M），Protalix BioTherapeutics, Inc.净利率更高（-60.3% vs -6862.0%，领先6801.6%）
纽波特工艺酿酒蒸馏公司位于美国罗德岛州纽波特，1999年以滨海极限酿酒公司之名成立，是纽波特首家精酿微酿酒厂，2006年新增蒸馏业务，2018年改用现名以体现综合生产定位，目前生产多种啤酒与烈酒产品，分销网络覆盖美国东北部地区。
Protalix BioTherapeutics是一家以色列制药企业，核心产品为植物源酶制剂他利苷酶阿尔法，该产品已获美国食品药品监督管理局批准，用于治疗戈谢病，专注于开发创新生物技术药物服务患者需求。
IPST vs PLX — 直观对比
营收规模更大
PLX
是对方的1.9倍
$4.7M
净利率更高
PLX
高出6801.6%
-6862.0%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $4.7M | $9.1M |
| 净利润 | $-323.7M | $-5.5M |
| 毛利率 | 68.5% | 49.4% |
| 营业利润率 | -2622.6% | -51.1% |
| 净利率 | -6862.0% | -60.3% |
| 营收同比 | — | -49.9% |
| 净利润同比 | — | -184.8% |
| 每股收益（稀释后） | $-31.89 | $-0.06 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收IPSTPLX
| Q4 25 | $4.7M | $9.1M | ||
| Q3 25 | $3.0M | $17.9M | ||
| Q2 25 | $1.3M | $15.7M | ||
| Q1 25 | $1.1M | $10.1M | ||
| Q4 24 | — | $18.2M | ||
| Q3 24 | $1.8M | $18.0M | ||
| Q2 24 | — | $13.5M | ||
| Q4 23 | — | $10.5M |
净利润IPSTPLX
| Q4 25 | $-323.7M | $-5.5M | ||
| Q3 25 | $196.3M | $2.4M | ||
| Q2 25 | $-7.3M | $164.0K | ||
| Q1 25 | $-3.0M | $-3.6M | ||
| Q4 24 | — | $6.5M | ||
| Q3 24 | $-3.4M | $3.2M | ||
| Q2 24 | — | $-2.2M | ||
| Q4 23 | — | $-6.0M |
毛利率IPSTPLX
| Q4 25 | 68.5% | 49.4% | ||
| Q3 25 | 61.3% | 53.4% | ||
| Q2 25 | 17.2% | 62.5% | ||
| Q1 25 | 24.9% | 19.1% | ||
| Q4 24 | — | 78.7% | ||
| Q3 24 | 35.8% | 53.4% | ||
| Q2 24 | — | 29.8% | ||
| Q4 23 | — | 15.5% |
营业利润率IPSTPLX
| Q4 25 | -2622.6% | -51.1% | ||
| Q3 25 | -38.4% | 11.9% | ||
| Q2 25 | -503.0% | 7.5% | ||
| Q1 25 | -224.5% | -41.0% | ||
| Q4 24 | — | 39.6% | ||
| Q3 24 | -118.1% | 22.2% | ||
| Q2 24 | — | -18.0% | ||
| Q4 23 | — | -53.5% |
净利率IPSTPLX
| Q4 25 | -6862.0% | -60.3% | ||
| Q3 25 | 6566.2% | 13.2% | ||
| Q2 25 | -551.9% | 1.0% | ||
| Q1 25 | -277.8% | -35.8% | ||
| Q4 24 | — | 35.6% | ||
| Q3 24 | -194.9% | 18.0% | ||
| Q2 24 | — | -16.4% | ||
| Q4 23 | — | -57.6% |
每股收益（稀释后）IPSTPLX
| Q4 25 | $-31.89 | $-0.06 | ||
| Q3 25 | $16.97 | $0.03 | ||
| Q2 25 | $-0.77 | $0.00 | ||
| Q1 25 | $-0.34 | $-0.05 | ||
| Q4 24 | — | $0.10 | ||
| Q3 24 | $-160.41 | $0.03 | ||
| Q2 24 | — | $-0.03 | ||
| Q4 23 | — | $-0.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $14.7M |
| 总债务越低越好 | $2.6M | — |
| 股东权益账面价值 | $98.2M | $48.2M |
| 总资产 | $108.8M | $82.3M |
| 负债/权益比越低杠杆越低 | 0.03× | — |
8季度趋势，按日历期对齐
现金及短期投资IPSTPLX
| Q4 25 | — | $14.7M | ||
| Q3 25 | — | $13.6M | ||
| Q2 25 | — | $17.9M | ||
| Q1 25 | — | $19.5M | ||
| Q4 24 | — | $19.8M | ||
| Q3 24 | — | $27.4M | ||
| Q2 24 | — | $23.4M | ||
| Q4 23 | — | $23.6M |
总债务IPSTPLX
| Q4 25 | $2.6M | — | ||
| Q3 25 | $2.6M | — | ||
| Q2 25 | $13.0M | — | ||
| Q1 25 | $13.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $15.0M | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
股东权益IPSTPLX
| Q4 25 | $98.2M | $48.2M | ||
| Q3 25 | $420.4M | $52.9M | ||
| Q2 25 | $-2.9M | $49.9M | ||
| Q1 25 | $-329.0K | $45.2M | ||
| Q4 24 | — | $43.2M | ||
| Q3 24 | $-34.0M | $32.4M | ||
| Q2 24 | — | $28.6M | ||
| Q4 23 | — | $33.6M |
总资产IPSTPLX
| Q4 25 | $108.8M | $82.3M | ||
| Q3 25 | $482.8M | $82.3M | ||
| Q2 25 | $26.5M | $78.5M | ||
| Q1 25 | $27.1M | $73.9M | ||
| Q4 24 | — | $73.4M | ||
| Q3 24 | $31.1M | $61.6M | ||
| Q2 24 | — | $91.5M | ||
| Q4 23 | — | $84.4M |
负债/权益比IPSTPLX
| Q4 25 | 0.03× | — | ||
| Q3 25 | 0.01× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-7.5M | $2.0M |
| 自由现金流经营现金流 - 资本支出 | — | $1.6M |
| 自由现金流率自由现金流/营收 | — | 17.8% |
| 资本支出强度资本支出/营收 | 0.0% | 4.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-13.6M |
8季度趋势，按日历期对齐
经营现金流IPSTPLX
| Q4 25 | $-7.5M | $2.0M | ||
| Q3 25 | $-4.3M | $-3.7M | ||
| Q2 25 | $-1.5M | $-5.2M | ||
| Q1 25 | $-2.0M | $-5.1M | ||
| Q4 24 | — | $4.0M | ||
| Q3 24 | — | $4.1M | ||
| Q2 24 | — | $-3.6M | ||
| Q4 23 | — | $3.6M |
自由现金流IPSTPLX
| Q4 25 | — | $1.6M | ||
| Q3 25 | $-4.3M | $-4.2M | ||
| Q2 25 | $-1.5M | $-5.7M | ||
| Q1 25 | $-2.0M | $-5.4M | ||
| Q4 24 | — | $3.6M | ||
| Q3 24 | — | $4.0M | ||
| Q2 24 | — | $-3.8M | ||
| Q4 23 | — | $3.3M |
自由现金流率IPSTPLX
| Q4 25 | — | 17.8% | ||
| Q3 25 | -144.7% | -23.7% | ||
| Q2 25 | -115.3% | -36.2% | ||
| Q1 25 | -187.6% | -53.0% | ||
| Q4 24 | — | 19.6% | ||
| Q3 24 | — | 22.4% | ||
| Q2 24 | — | -28.1% | ||
| Q4 23 | — | 31.9% |
资本支出强度IPSTPLX
| Q4 25 | 0.0% | 4.4% | ||
| Q3 25 | 1.5% | 2.8% | ||
| Q2 25 | 0.9% | 2.8% | ||
| Q1 25 | 1.6% | 3.0% | ||
| Q4 24 | — | 2.3% | ||
| Q3 24 | — | 0.5% | ||
| Q2 24 | — | 1.3% | ||
| Q4 23 | — | 2.4% |
现金转化率IPSTPLX
| Q4 25 | — | — | ||
| Q3 25 | -0.02× | -1.58× | ||
| Q2 25 | — | -31.91× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.61× | ||
| Q3 24 | — | 1.27× | ||
| Q2 24 | — | — | ||
| Q4 23 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
IPST
| Direct To Consumer | $3.0M | 63% |
| Wholesale | $1.2M | 26% |
| Other | $517.7K | 11% |
PLX
| Products | $8.7M | 95% |
| Other | $428.0K | 5% |
